RBA
AVNS

Richard Bernstein Advisors’s Avanos Medical AVNS Stock Holding History

Richard Bernstein Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-101,535
Closed -$4.44M – 319
2021
Q1 		$4.44M Hold
101,535
– – 0.1% 95
2020
Q4 		$4.66M Buy
+101,535
New +$4.23M 0.11% 85
2015
Q2 		– Sell
-5,133
Closed -$253K – 198
2015
Q1 		$253K Hold
5,133
– – 0.03% 197
2014
Q4 		$233K Buy
+5,133
New +$202K 0.02% 243

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Richard Bernstein Advisors's AVNS Position: Q2 2021 in Review

Richard Bernstein Advisors sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 101,535 shares — an estimated $4.44M sold.

Richard Bernstein Advisors first reported a position in AVNS in Q4 2014 and held it in 4 quarters. The position peaked at $4.66M in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • Richard Bernstein Advisors reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • Richard Bernstein Advisors sold 101,535 Avanos Medical shares in Q2 2021, an estimated $4.44M.
  • Richard Bernstein Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 4 quarters.
  • Richard Bernstein Advisors's Avanos Medical position peaked at $4.66M in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Richard Bernstein Advisors's 13F filing for Q2 2021, filed 5 Aug 2021.